Invention Grant
- Patent Title: Substituted benzimidazolone compounds
-
Application No.: US17609443Application Date: 2020-05-07
-
Publication No.: US12187723B2Publication Date: 2025-01-07
- Inventor: Alaric J. Dyckman , Laxman Pasunoori , Sreekantha Ratna Kumar , Srinivasan Kunchithapatham Duraisamy , Pitani Veera Venkata Srinivas , Vikram Bhogadi , Subramanya Hegde
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee Address: US NJ Princeton
- Agent Gary Greenblatt
- International Application: PCT/US2020/031799 WO 20200507
- International Announcement: WO2020/227484 WO 20201112
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D519/00

Abstract:
Disclosed are compounds of Formula (I) N-oxides, or salts thereof, wherein G, A, R1, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
Public/Granted literature
- US20220289739A1 SUBSTITUTED BENZIMIDAZOLONE COMPOUNDS Public/Granted day:2022-09-15
Information query